A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma. Issue 2 (13th January 2021) - Peereboom, David M; Ye, Xiaobu; Mikkelsen, Tom; Lesser, Glenn J; Lieberman, Frank S; Robins, H Ian; Ahluwalia, Manmeet S; Sloan, Andrew E; Grossman, Stuart A